PHA-680626
Product Specifications
CAS Number
398493-74-8
Target
Bcr-Abl, Aurora Kinase, Apoptosis, c-Myc, Histone Methyltransferase, Others
Related Pathways
Cell Cycle/Checkpoint, Others, Chromatin/Epigenetic, Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Angiogenesis, Apoptosis
Bioactivity
PHA-680626 is a potent and selective PLK inhibitor. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases. PHA-680626 inhibits Plk1 (IC50 = 0.53 μM), Plk2 (IC50 = 0.07 μM) and Plk3 (IC50 = 1.61 μM) .
Smiles
N(C(=O)C1=CC=C(C=C1)N2CCN(C)CC2)C=3C4=C(CN(C(CC5=CC=CS5)=O)C4)NN3
Molecular Formula
C23H26N6O2S
Molecular Weight
450.56
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6166443-01 0.1 mL
ULK2 (unc-51-like Kinase 2 (C. elegans), KIAA0623, Unc51.2) (APC)
Sign In for Pricing
View Details MBS6166443-02 5x 0.1 mL
ULK2 (unc-51-like Kinase 2 (C. elegans), KIAA0623, Unc51.2) (APC)
Sign In for Pricing
View Details 